A new Chimeric Drug Delivery nano System (chi-aDDnS) composed of PAMAM G 3.5 dendrimer and liposomes as Doxorubicin's carrier. In vitro pharmacological studies

Journal of Nanoscience and Nanotechnology

Volumn 11, Issue 5, 2011, Pages 3764-3772

  Gardikis, Konstantinos ^a   Fessas, Dimitrios ^b   Signorelli, Marco ^b   Dimas, Konstantinos ^c   Tsimplouli, Chrisiida ^c   Ionov, Maksim ^d   Demetzos, Costas ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF MILAN   (Italy)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^d UNIVERSITY OF LODZ   (Poland)

Author keywords

Chimeric advanced Drug Delivery NanoSystem (chi aDDnS); Differential scanning calorimetry; Doxorubicin; Fluorescence spectroscopy; In vitro cytotoxicity; PAMAM

Indexed keywords

CANCER CELL LINES; CHIMERIC ADVANCED DRUG DELIVERY NANOSYSTEM (CHI-ADDNS); COMBINATION PROCESS; DENDRIMER MOLECULES; DOXORUBICIN; DRUG CARRIER; IN VITRO CYTOTOXICITY; IN-VITRO; IN-VIVO; LIPOSOMAL MEMBRANES; NANOBIOMATERIALS; PAMAM; PHARMACOLOGICAL PROPERTIES; RELEASE RATE; STRONG INTERACTION;

CELL CULTURE; DENDRIMERS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY; FLUORESCENCE SPECTROSCOPY; LIPOSOMES; PHOSPHOLIPIDS;

NANOSYSTEMS;

ANTINEOPLASTIC AGENT; DENDRIMER; DOXORUBICIN; LIPOSOME;

ARTICLE; DRUG DELIVERY SYSTEM; HUMAN; MEMBRANE FLUIDITY; NANOTECHNOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DENDRIMERS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; MEMBRANE FLUIDITY; NANOTECHNOLOGY;

EID: 80051586182     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2011.3847     Document Type: Conference Paper

References (62)

1. F. Alexis, J.-W. Rhee, J. P. Richie, A. F. Radovic-Moreno, R. Langer, and O. C. Farokhzad, Urol Oncol Semin O I 26, 74(2008).
2. P. Couvreur, R. Gref, K. Andrieux, and C. Malvy, Prog. Solid State Chem. 34, 231(2006).
3. S. J. Choi, J. M. Oh, and J. H. Choy, J. Ceram. Sci. Jpn. 117, 543(2009).
4. S. H. Pun, N. C. Bellocq, A. Liu, G. Jensen, T. Machemer, E. Quijano, T. Schluep, S. Wen, H. Engler, J. Heidel, and M. E. Davis, Bioconjugate Chem. 15, 831(2004).
5. Y. Cirpanli, E. Bilensoy, A. L. Dogan, and S. Calis, Eur. J. Pharm. Biopharm. 73, 82(2009).
6. J. Kost and R. Langer, Adv. Drug Deliver Rev. 46, 125(2001).
7. D. B. Shenoy and M. M. Amiji, Int. J. Pharm. 293, 261(2005).
8. H. Shmeeda, L. Mak, D. Tzemach, P. Astrahan, M. Tarshish, and A. Gabizon, Mol. Cancer Ther. 5, 818(2006).
9. J. L. Arias, V. Gallardo, F. Linares-Molinero, and A. V. Delgado, J. Colloid Inerface Sci. 299, 599(2006).
10. Y. Matsumura, Jpn. J. Clin. Oncol. 38, 793(2008).
11. Y. Matsumura and K. Kataoka, Cancer Sci. 100, 572(2009).
12. K. K. Upadhyay, H. G. Agrawal, C. Upadhyay, C. Schatz, J. F. Le Meins, A. Misra, and S. Lecommandoux, Crit. Rev. Ther. Drug 26, 157(2009).
13. L. Yang, X. H. Wu, F. Liu, Y. R. Duan, and S. M. Li, Pharm. Res. 26, 2332(2009).
14. P. L. Kuo, W. J. Liang, and F. Y. Wang, J. Polym. Sci. Pol. Chem. 41, 1360(2003).
15. P. L. Kuo, W. J. Liang, and F. Y. Wang, Colloid. Polym. Sci. 284, 435(2006).
16. M. T. Morgan, M. A. Carnahan, C. E. Immoos, A. A. Ribeiro, S. Finkelstein, S. J. Lee, and M. W. Grinstaff, J. Am. Chem. Soc. 125, 15485(2003).
17. F. Wang, T. K. Bronich, A. V. Kabanov, R. D. Rauh, and J. Roovers, Bioconjucate Chem. 16, 397(2005).
18. T. Ooya, J. Lee, and K. Park, Bioconjucate Chem. 15, 1221(2004).
19. M. F. Neerman, H.-T. Chen, A. R. Parrish, and E. E. Simanek, Mol. Pharmacol. 1, 390(2004).
20. J. B. Wolinsky and M. W. Grinstaff, Adv. Drug Deliver Rev. 60, 1037(2008).
21. A. Y. Bedikian, N. E. Papadopoulos, K. B. Kim, A. Vardeleon, T. Smith, B. Lu, and S. R. Deitcher, Melanoma Res. 18, 400(2008).
22. T. H. Chow, Y. Y. Lin, J. J. Hwang, H. E. Wang, Y. L. Tseng, V. F. Pang, S. J. Wang, J. Whang-Peng, and G. Ting, Nucl. Med. Biol. 35, 623(2008).
23. Y. Hattori, L. Shi, W. X. Ding, K. Koga, K. Kawano, M. Hakoshima, and Y. Maitani, J. Controlled Release 136, 30(2009).
24. X. M. Li, L. Y. Ding, Y. L. Xu, Y. L. Wang, and Q. N. Ping, Int. J. Pharm. 373, 116(2009).
25. C. O. Noble, Z. X. Guo, M. E. Hayes, J. D. Marks, J. W. Park, C. C. Benz, D. B. Kirpotin, and D. C. Drummond, Cancer Chemoth. Pharm. 64, 741(2009).
26. R. A. Schwendener, Adv. Exp. Med. Biol. 620, 117(2007).
27. J. Turanek, X. F. Wang, P. Knotigova, S. Koudelka, L. F. Dong, E. Vrublova, E. Mahdavian, L. Prochazka, S. Sangsura, A. Vacek, B. A. Salvatore, and J. Neuzil, Toxicol. Appl. Pharmacol. 237, 249(2009).
28. S. A. Abraham, D. N. Waterhouse, L. D. Mayer, P. R. Cullis, T. D. Madden, and M. B. Bally, Method Enzymol. 391, 71(2005).
29. U. Massing and S. Fuxius, Drug Resist Update 3, 171(2000).
30. R. M. Schiffelers and G. Storm, Int. J. Pharm. 364, 258(2008).
31. S. Hatziantoniou, K. Dimas, A. Georgopoulos, N. Sotiriadou, and C. Demetzos, Pharmacol. Res. 53, 80(2006).
32. K. Miyajima, Adv. Drug Deliver Rev. 24, 151(1997).
33. E. Buhleier, W. Wehner, and F. Vogtle, Synthesis-Stuttgart 155(1978).
34. D. A. Tomalia, A. M. Naylor, and W. A. Goddard, Angew Cem. Int. Edit. 29, 138(1990).
35. D. A. Tomalia and J. M. J. Fréchet, J. Pol. Sci. A 140, 2719(2002).
36. R. Esfand and D. A. Tomalia, Drug Discovery Today 6, 427(2001).
37. E. R. Gillies and J. M. J. Frechet, J. Am. Chem. Soc. 124, 14137(2002).
38. E. R. Gillies and J. M. J. Frechet, Drug Discovery Today 10, 35(2005).
39. S. Svenson and D. A. Tomalia, Adv. Drug Deliver Rev. 57, 2106(2005).
40. A. J. Khopade, F. Caruso, P. Tripathi, S. Nagaich, and N. K. Jain, Int. J. Pharm. 232, 157(2002).
41. G. Purohit, T. Sakthivel, and A. T. Florence, Int. J. Pharm. 214, 71(2001).
42. S. Ballut, A. Makky, B. Loock, J. P. Michel, P. Maillard, and V. Rosilio, Chem. Commun. 224(2009).
43. K. Gardikis, S. Hatziantoniou, M. Bucos, D. Fessas, M. Signorelli, T. Felekis, M. Zervou, C. G. Screttas, B. R. Steele, M. Ionov, M. Micha-Screttas, B. Klajnert, M. Bryszewska, and C. Demetzos, J. Pharm. Sci. 99, 3561(2010).
44. M. L. Moraes, M. S. Baptista, R. Itri, V. Zucolotto, and O. N. Oliveira, Jr., Mater. Sci. Eng., C 28, 467(2008).
45. A. Papagiannaros, K. Dimas, G. T. Papaioannou, and C. Demetzos, Int. J. Pharm. 302, 29(2005).
46. K. Gardikis, S. Hatziantoniou, M. Signorelli, M. Pusceddu, M. Micha-Screttas, A. Schiraldi, C. Demetzos, and D. Fessas, Colloid Surf., B 81, 11(2010).
47. R. K. Tekade, P. V. Kumar, and N. K. Jain, Chem. Rev. 109, 49(2009).
48. C. Demetzos, Drug delivery nanosystems and their classification based on their dynamic variability, 2nd International Symposium on Biological Applications of Dendrimers, Porquerolles Island, France, June (2010).
49. C. Demetzos, Advances in drug delivery systems (DDSs). International Congress on New Delivery Systems, Biosimilars, Bioequivalence-Biowaivers- Biotechnology Products, Athens, Greece, July (2010).
50. F. Szoka and D. Papahadjopoulos, Proceedings of the National Academy of Sciences of the United States of America 75, 4194(1978).
51. N. Wang, T. Wang, T. F. Li, and Y. J. Deng, Colloid Surf., B 69, 232(2009).
52. S. Hatziantoniou and C. Demetzos, J. Lipos. Res. 16, 321(2006).
53. G. Barone, P. Del Vecchio, D. Fessas, C. Giancola, and G. Graziano, Therm. Anal. Calorim. 38, 2779(1992).
54. K. Gardikis, K. Dimas, A. Georgopoulos, E. Kaditi, S. Pispas, and C. Demetzos, Cur. Nanosci. 6, 277(2010).
55. A. Fritze, F. Hens, A. Kimpfler, R. Schubert, and R. Peschka-Suss, BBA-Biomembranes 1758, 1633(2006).
56. E. C. A. van Winden and D. J. A. Crommelin, Eur. J. Pharm. Biopharm. 43, 295(1997).
57. G. J. R. Charrois and T. M. Allen, BBA-Biomembranes 1663, 167(2004).
58. L. D. Mayer, L. C. L. Tai, D. S. C. Ko, D. Masin, R. S. Ginsberg, P. R. Cullis, and M. B. Bally, Cancer Res. 49, 5922(1989).
59. V. P. Ivanova, I. M. Makarov, T. E. Schaffer, and T. Heimburg, Biophys. J. 84, 2427(2003).
60. E. Freire, T. Markello, C. Rigell, and P. W. Holloway, Biochemistry-US 22, 1675(1983).
61. K. Gardikis, S. Hatziantoniou, K. Viras, M. Wagner, and C. Demetzos, Int. J. Pharm. 318, 118(2006).
62. B. Klajnert and R. M. Epand, Int. J. Pharm. 305, 154(2005).